- Flow Cytometer
- Hematology Analyzers
- Reagents and Kits
Cell Surface Markers Market was valued at USD 631 million in 2022 and is poised to grow at a significant CAGR of 8.2% from 2023-2029. Bladder diseases is an umbrella term used to depict neurotic conditions that influence the structure or capacity of the bladder. Bladder ailments incorporate conditions identified with irritation, disease and urinary incontinence. Cell Surface Markers Market is a remote therapeutic gadget that utilizations high-recurrence sound waves to produce a picture of the bladder of the individual. The major drivers of the global market includes expansion of human services innovation and decrease the cost of ailment determination. The expansion in frequency of tumor and other immune system sickness fortifying the interest for the improvement of disentanglement of infections recognizable proof and the rising mechanization of arrangements and advancements are anticipated to fuel the market. Additionally, expanded research for the use of undeveloped cell innovation is profiting the part to develop. Nonetheless, the central point which are limiting cell surface markers identification developments are intricate items and costly instruments and reagents utilized as a part of cell marker investigation. The market is expected to gain huge traction due to advancements in fluorescence innovation, improvements of cytometric procedures. Presentation of fluorescence-enacted cell arranging (FACS) calculations for fast and quantitative examination of cells is foreseen to fuel industry development in future. Companies are focused on joint ventures with different players in the business to enhance market presence.
The Cell Surface Markers Market Key Development :
- In April 2014, Beckman Coulter Life Sciences declared the securing of Xitogen Technologies, a cytometer producer. This securing encourages Beckman Coulter to expand its item contributions and empowers business development in Asia.
Global Cell Surface Markers Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.2%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Cell Surface Markers Market Dynamics
The market's growth is projected to be hampered by a lack of willingness to invest heavily in advanced models. Many clinical laboratories are hesitant to invest in sophisticated cell marker analysis tools due to the complexity and high cost of instruments, as well as the uncertainty surrounding the regulation and reimbursement of cell marker diagnostic procedures. The size and nature of the diagnostic facility also influence the need for such instruments. Outsourcing of such jobs to larger clinical laboratories is a result of economic concerns about operational sustainability in medium and small clinical laboratories and hospitals.
North-America Got Significant Share
Cell Surface Markers Market Regional Analysis
Geographically Cell Surface Markers Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America leads the worldwide cell surface markers market followed by Europe. North America rules the market due the nearness of significant key players and ceaseless complex R&D innovation advancement in the locale. Social insurance foundation change and developing inclination for simpler and more secure focused on treatments are the main considerations which powers the market development in these areas. Also, the expanding frequency rate of tumor and other incessant infection prompt request of demonstrative request enlarging for the North America market. APAC is relied upon to witness critical development when contrasted with different locales and nations inferable from expanded medicinal services and research use. Additionally, the quick increment in geriatric populace base moving local industry development.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Cell Surface Markers Market Segmentation
By Reagent Type
By Application
- Disease Diagnosis
- Research and Drug Discovery
By End-User
- Hospitals
- Homecare
- Ambulatory Care Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- MEA
Frequently Asked Questions
Increased Use of Cell Surface Markers Detection in Diagnostics
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Cell Surface Markers Market was valued at USD 631 million in 2022 and is poised to grow at a significant CAGR of 8.2% from 2023-2029.
The Cell Surface Markers Market faces threats such as increasing competition, regulatory challenges, and potential limitations in technology advancements.
| 1.Executive Summary |
| 2.Global Cell Surface Markers Market Introduction |
| 2.1.Global Cell Surface Markers Market - Taxonomy |
| 2.2.Global Cell Surface Markers Market - Definitions |
| 2.2.1.Reagent Type |
| 2.2.2.Application |
| 2.2.3.End-User |
| 2.2.4.Region |
| 3.Global Cell Surface Markers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Cell Surface Markers Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cell Surface Markers Market By Reagent Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Flow Cytometer |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Hematology Analyzers |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Reagents and Kits |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Cell Surface Markers Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Disease Diagnosis |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Research and Drug Discovery |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Cell Surface Markers Market By End-User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Homecare |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Care Centers |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Cell Surface Markers Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Cell Surface Markers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Reagent Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Flow Cytometer |
| 9.1.2.Hematology Analyzers |
| 9.1.3.Reagents and Kits |
| 9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Disease Diagnosis |
| 9.2.2.Research and Drug Discovery |
| 9.3. End-User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Homecare |
| 9.3.3.Ambulatory Care Centers |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Cell Surface Markers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Flow Cytometer |
| 10.1.2.Hematology Analyzers |
| 10.1.3.Reagents and Kits |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Disease Diagnosis |
| 10.2.2.Research and Drug Discovery |
| 10.3. End-User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Homecare |
| 10.3.3.Ambulatory Care Centers |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Cell Surface Markers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Flow Cytometer |
| 11.1.2.Hematology Analyzers |
| 11.1.3.Reagents and Kits |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Disease Diagnosis |
| 11.2.2.Research and Drug Discovery |
| 11.3. End-User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Homecare |
| 11.3.3.Ambulatory Care Centers |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Cell Surface Markers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Flow Cytometer |
| 12.1.2.Hematology Analyzers |
| 12.1.3.Reagents and Kits |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Disease Diagnosis |
| 12.2.2.Research and Drug Discovery |
| 12.3. End-User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Homecare |
| 12.3.3.Ambulatory Care Centers |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Cell Surface Markers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Flow Cytometer |
| 13.1.2.Hematology Analyzers |
| 13.1.3.Reagents and Kits |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Disease Diagnosis |
| 13.2.2.Research and Drug Discovery |
| 13.3. End-User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Homecare |
| 13.3.3.Ambulatory Care Centers |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Beckman Coulter, Inc. (U.S.) |
| 14.2.2.Becton, Dickinson and Company (U.S.) |
| 14.2.3.Thermo Fisher Scientific, Inc. (U.S.) |
| 14.2.4.Merck&Co., Inc. (US) |
| 14.2.5.Luminex Corporation (U.S.) |
| 14.2.6.Sysmex Partec GmbH (Germany) |
| 14.2.8.Miltenyi Biotec GmbH (Germany) |
| 14.2.9.Sony Biotechnology (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Beckman Coulter, Inc. (U.S.)
- Becton, Dickinson and Company (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Merck&Co., Inc. (US)
- Luminex Corporation (U.S.)
- Sysmex Partec GmbH (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Miltenyi Biotec GmbH (Germany)
- Sony Biotechnology (U.S.)